The efficacy and safety of CD7 chimeric antigen receptor T-cell therapy for hematologic malignancies: a systematic review and meta-analysis
Jile Liu(Tianjin Medical University), Mingfeng Zhao(Tianjin First Center Hospital), Xuejin Gao(Tianjin First Center Hospital), Shujing Guo(Tianjin Medical University), Rui Sun(Nankai University), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Yuxin An(Tianjin Medical University)
Cited by 2
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Extracellular Histones Are Mediators of Death through TLR2 and TLR4 in Mouse Fatal Liver Injury
|The Journal of Immunology|2011|522
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316